Table 2.
Prioritized list of outcomes for a trial in incremental hemodialysis
| Outcomes | Group A1 (n = 7) | Group A2 (n = 5) | Group B1 (n = 4) | Group B2 (n = 5) | Group B3 (n = 4) | Total Score |
|---|---|---|---|---|---|---|
| Quality of life | 12 | 11 | 9 | 13 | 11 | 56 |
| Residual kidney function | 16 | 3 | 8 | - | - | 27 |
| Mortality | 2 | 2 | 1 | 8 | 3 | 16 |
| Fluid overload | - | 5.5a | 1 | 4 | 2 | 12.5a |
| Ability to work | - | 7 | 3 | - | - | 10 |
| Vascular access function | 6 | - | - | - | 2 | 8 |
| Symptom burden | 2 | 3 | - | - | 3 | 8 |
| Hospitalizations (or avoidance thereof) | 2 | - | - | 3 | - | 5 |
| Major CVE | - | 2 | - | - | 1 | 3 |
| Nutritional status | - | 0.5a | 2 | - | - | 2.5a |
| High potassium | - | - | - | 2 | - | 2 |
| Impact on familyb | - | - | - | - | 2 | 2 |
| Suitability for kidney transplantationb | 1 | - | - | - | - | 1 |
| Duration of incremental HDb | 1 | - | - | - | - | 1 |
| Complete loss of urine output | - | - | - | - | - | 0 |
| Health care-related costs | - | - | - | - | - | 0 |
| Impact on fertilityb | - | - | - | - | - | 0 |
CVE, cardiovascular events; HD, hemodialysis.
Points calculated by adding individual participants’ outcome priority scores: most important outcome = 3 points, second = 2 points and third = 1 point.
Two participants had no third outcomes hence 2 scoring points missing from final table.
a
Two participants preferred to split their single point across 2 items resulting in half point allocations.
b
New outcomes identified.